Antisense oligonucleotides are provided which are complementary to and hybridizable with at least a portion of HCV RNA and which are capable of inhibiting the function of the HCV RNA. These oligonucleotides can be administered to inhibit the activity of Hepatitis C virus in vivo or in vitro. These compounds can be used either prophylactically or therapeutically to reduce the severity of diseases associated with Hepatitis C virus, and for diagnosis and detection of HCV and HCV-associated diseases. Methods of using these compounds are also disclosed.

 
Web www.patentalert.com

< Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization

< Macrolides with antibacterial activity

> Method of delaying the onset of diabetes

> Adenosine cyclic ketals: novel adenosine analogues for pharmacotherapy

~ 00237